Navigation Links
Carboplatin, Lung cancer drug may be useful in treating breast tumor

If breast cancer in women has occurred because of two common genetic mutations, it may be possible to seek remedy from a prevalent chemotherapy medication. Carboplatin, which is being used// to treat ovarian and lung cancers, is getting known for its success rates in treating breast tumors.

British scientists have conducted a research on mice which has revealed that cancer cells with BRCA2 mutations are twenty times more receptive to carboplatin, and that BRCA1 tumors are between five and twenty times more receptive.

The scientists will be testing this finding on 150 BRCA breast cancer patients, 75 with each mutation, who will be administered carboplatin or docetaxel, to check out which one is more effective. If the clinical trials prove successful, then it will be used to treat breast cancer patients with BRCA mutations within 5 years.

Andrew Tutt, consultant oncologist at Guy’s and St Thomas’ NHS Foundation Trust in London, who is leading the trial, said: “There is an increasing realisation that breast cancer is not just one disease, but that different types of tumor will respond differently to particular drugs. This genetically tailored chemotherapy treatment acts in a much more focused manner than standard chemotherap.”
'"/>




Page: 1

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Want skin cancer? Please have a cigarette
3. New hope for cancer victims – will vaccine cure the deadly bug
4. Clintons new problem - Is the outgoing American president suffering from skin cancer?
5. Are cancer patients being taken for a ride?
6. Breast cancer treatment to be determined by gene test
7. Ductal lavage may detect early breast cancer
8. Beware of the oral patch! It could be cancer!!!
9. New drug helps boost cancer treatment
10. Antidepressants come in handy for patients on treatment for hepatitis, cancers and multiple sclerosis
11. Lose stomach for Life....Preventive removal of stomach saves the risk of cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Carboplatin Lung cancer drug may useful treating breast tumor

(Date:7/23/2014)... have been focused on the regions of the coding ... form of amino acids thus proteins. But just before ... which controls the expression and activity of the adjacent ... role exerted such DNA fragment in tumor development. ... in collaboration with the group of Manel Esteller, Director ...
(Date:7/23/2014)... therapy combining salmon fibrin injections into the spinal cord ... restored voluntary motor function impaired by spinal cord injury, ... , In a study on rodents, Gail Lewandowski and ... developmental clock in a molecular pathway critical to the ... scaffold so that neuronal axons at the injury site ...
(Date:7/23/2014)... 23, 2014 This report defines and ... (Asia-Pacific, Europe, the Middle East & Africa, and Americas) ... and geography with analysis and forecasts of the global ... grow from over $10 billion in 2014 to nearly ... 5%. , browse 49 Market Tables and 10 ...
(Date:7/23/2014)... Battle Creek, MI (PRWEB) July 23, 2014 ... treatment program that gets clients off to a great ... they can believe in, has launched a new Internet ... , “Many people are surprised to learn that Internet ... sexual addiction or drug addiction, but that it’s trapping ...
(Date:7/23/2014)... (HealthDay News) -- Children and teens who lose a parent ... adulthood, a new study suggests. People who were children ... greater risk of death during the study period than those ... to the report. Although the study found an association ... premature death, it wasn,t designed to prove cause-and-effect. Also, ...
Breaking Medicine News(10 mins):Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 2Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 3Health News:EHV Transmission Market $14 Billion by 2019 - Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Internet Addiction Section on Website 2Health News:Parent's Death May Raise Risk of Early Death for Grown Children, Study Suggests 2
... curb dementia, researchers say, , , TUESDAY, Nov. 18 (HealthDay ... new research suggests that the herb ginkgo biloba won,t ... found that giving a standardized dose of ginkgo biloba ... the incidence rate of dementia or Alzheimer,s disease," said ...
... of allergic reactions, other problems have surfaced with these ... - American women who turn to cosmetic treatments called ... as to the health risks these products pose, an ... recommended Tuesday. , The panel of independent experts urged ...
... , RESTON, Va., Nov. 18 ... D prescription drug benefit in 2008 are satisfied with their ... nationwide education and advocacy group for older Americans. , ... Similar surveys conducted over the last year found the same ...
... now the only over the counter treatment for chronic and acute ... prevents contamination of wounds and speeds up the healing process. ... ... the development of Wound-Be-Gone, all skin injuries, especially large, chronic wounds, ...
... 18 (Nasdaq: WHRTD ) World,Heart Corporation ... 2008, the Company received a letter from The NASDAQ ... with Marketplace,Rule 4310(c)(4) (the "Minimum Bid Price Rule") and ... at $1.00 per share or greater for at least ...
... WASHINGTON, Nov. 18 Over 2 million low-income Medicare,beneficiaries ... in,January. Changes to the 2009 Medicare Part D plans ... premiums they cannot afford or limit,access to their prescriptions, ... Law Center (NSCLC). Part D open enrollment runs from ...
Cached Medicine News:Health News:Ginkgo No Shield Against Alzheimer's 2Health News:Ginkgo No Shield Against Alzheimer's 3Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 2Health News:Wrinkle Fillers Need Better Label Warnings: FDA Panel 3Health News:New Survey Shows Seniors Overwhelmingly Satisfied With Medicare Part D 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 2Health News:A Revolution in Wound Healing, Wound-Be-Gone Now the Only Over the Counter Treatment for Chronic and Acute Wounds 3Health News:WorldHeart Regains Compliance With the Minimum Bid Price Rule 2Health News:2009 Medicare Part D Premiums to Rise Dramatically: Over 2 Million Low Income Beneficiaries At Risk 2
(Date:7/23/2014)... 2014 /PRNewswire-iReach/ -- The Centers for Medicare & Medicaid ... Network-Quality Improvement Organization (QIN-QIO) contract to a partnership led ... Effective August 1, WVMI will launch Quality Insights Quality ... Pennsylvania , Delaware ... The Network will engage providers and the community in ...
(Date:7/23/2014)... July 23, 2014 Research and ... "Global Electrophysiology Ablation Catheters Market 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Catheter ablation is ... destroy faulty electrical pathways from sections of the ... as cardiac arrhythmias). Cardiac arrhythmias can be of ...
(Date:7/23/2014)... Creekridge Capital, an independent vendor-focused finance ... so far in 2014 to their portfolio of ... from both the healthcare and technology industries. They ... multi-national companies. Each of these new vendors take ... including: standard leasing products, subscription solutions, a dedicated ...
Breaking Medicine Technology:Announcing a New Regional Approach to Medicare Quality Improvement 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3Creekridge Capital Signs Several New Vendor Partners 2
... WIRE)--May 30, 2007 - INNOVIVE Pharmaceuticals,Inc. (OTCBB: ... a Phase I,trial of INNO-406, an orally ... or,treatment-intolerant chronic myelogenous leukemia, will be,presented at ... Annual,Meeting. The meeting takes place June 1- ...
... from various,clinical studies including a pivotal Phase III trial ... Nexavar (sorafenib) tablets will be presented at the Annual,Meeting ... USA from June 1 - 5, 2007. , On ... be held on June 4, 2007. Starting at around ...
Cached Medicine Technology:Innovive Pharmaceuticals to Present Interim Data from Phase I Study,of INNO-406 at the American Society of Clinical Oncology Annual,Meeting 2
All the power and performance of the STS - T but now available with a stand-alone 9" II C-Arm...
... SL1 developed by STORZ MEDICAL is the ... in the field of kidney stone lithotripsy ... requirements to be met by orthopaedic apparatus ... been outlined above. The MINILITH SL1 is ...
... transportable, the Dornier Compact Delta lithotripsy system features ... patient. The systems shock source and C-arm are ... avoid the risk of misalignment. The therapy head ... its motorized lateral and horizontal movement and can ...
Used for temporary urine collection. The leg bag is designed for use with the Non-Adhesive Silicone Condom Catheter. Supplied non-sterile. Reusable. Intended for single patient use only....
Medicine Products: